{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T15:38:52Z","timestamp":1791041932798,"version":"4.1.0"},"reference-count":49,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T00:00:00Z","timestamp":1655078400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Common cardiac abnormalities in Noonan syndrome (NS) include congenital heart diseases (CHD), pulmonary valve stenosis and hypertrophic cardiomyopathy (HCM). Molecular diagnoses are enabling earlier and more precise diagnosis of patients who have a subtle or atypical presentation. The aims of this study were to investigate genotype-phenotype associations with respect to Noonan syndrome (NS)-associated cardiac abnormalities and catheter or surgery-based interventions conditions.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> From January 2019 to December 2021, 22 children with a confirmed molecular diagnosis of NS combined with cardiovascular abnormalities were consecutively enrolled into the current study. A comprehensive review was carried out of echocardiography and electrocardiogram results, second-generation whole-exome sequencing results and catheter or surgery-based interventions conditions.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> The main manifestations of electrocardiogram abnormalities were QTc prolongation, abnormal Q wave in the precordial lead and limb lead, right ventricular hypertrophy and left or right deviation of the electrical axis. The most commonly detected abnormality was pulmonary valve dysplasia with stenosis, seen in 15 (68.2%) patients, followed by atrial septal defect in 11 (50%) patients. Seven genes (<jats:italic>RAF1<\/jats:italic>, <jats:italic>RIT1<\/jats:italic>, <jats:italic>SOS1<\/jats:italic>, <jats:italic>PTPN11<\/jats:italic>, <jats:italic>BRAF<\/jats:italic>, <jats:italic>SOS2<\/jats:italic>, and <jats:italic>LZTR1<\/jats:italic>) were found to contain disease-associated variants<jats:italic>.<\/jats:italic> The most commonly observed genetic mutations were <jats:italic>PTPN11<\/jats:italic> (27%) and <jats:italic>RAF1<\/jats:italic> (27%)<jats:italic>.<\/jats:italic> Each genotype was associated with specific phenotypic findings. <jats:italic>RIT1<\/jats:italic>, <jats:italic>SOS1<\/jats:italic>, <jats:italic>PTPN11<\/jats:italic>, and <jats:italic>SOS2<\/jats:italic> had common echocardiography features characterized by pulmonary valve stenosis, while <jats:italic>RAF1<\/jats:italic> was characterized by HCM. Interestingly, patients with <jats:italic>BRAF<\/jats:italic> mutations were not only characterized by HCM, but also by pulmonary valve stenosis. In the cohort there was only one patient carrying a <jats:italic>LZTR1<\/jats:italic> mutation characterized by left ventricle globose dilation. Ten cases underwent catheter or surgery-based interventions. All the operations had immediate results and high success rates. However, some of the cases had adverse outcomes during extended follow-up. Based on the genotype-phenotype associations observed during follow-up, <jats:italic>BRAF<\/jats:italic> and <jats:italic>RAF1<\/jats:italic> genotypes seem to be poor prognostic factors, and multiple interventions may be required for NS patients with severe pulmonary stenosis or myectomy for HCM.<\/jats:p><jats:p><jats:bold>Conclusions:<\/jats:bold> The identification of causal genes in NS patients has enabled the evaluation of genotype-cardiac phenotype relationships and prognosis of the disease. This may be beneficial for the development of therapeutic approaches.<\/jats:p>","DOI":"10.3389\/fgene.2022.915129","type":"journal-article","created":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T05:17:53Z","timestamp":1655097473000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":28,"title":["Cardiovascular Abnormalities and Gene Mutations in Children With Noonan Syndrome"],"prefix":"10.3389","volume":"13","author":[{"given":"Ling","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-mei","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-shui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,6,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1002\/ajmg.1320210313","article-title":"Noonan Syndrome: the Changing Phenotype","volume":"21","author":"Allanson","year":"1985","journal-title":"Am. J. Med. Genet."},{"key":"B2","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1016\/j.jacc.2019.01.066","article-title":"Hypertrophic Cardiomyopathy in Noonan Syndrome Treated by MEK-Inhibition","volume":"73","author":"Andelfinger","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/jhg.2015.114","article-title":"Recent Advances in RASopathies","volume":"61","author":"Aoki","year":"2016","journal-title":"J. Hum. Genet."},{"key":"B4","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1002\/humu.20748","article-title":"The RAS\/MAPK Syndromes: Novel Roles of the RAS Pathway in Human Genetic Disorders","volume":"29","author":"Aoki","year":"2008","journal-title":"Hum. Mutat."},{"key":"B5","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1093\/eurheartj\/ehaa554","article-title":"2020 ESC Guidelines for the Management of Adult Congenital Heart Disease","volume":"42","author":"Baumgartner","year":"20202021","journal-title":"Eur. Heart J."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ejechocard\/jen303","article-title":"Echocardiographic Assessment of Valve Stenosis: EAE\/ASE Recommendations for Clinical Practice","volume":"10","author":"Baumgartner","year":"2009","journal-title":"Eur. J. Echocardiogr."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2952","DOI":"10.1002\/ajmg.a.36722","article-title":"Further Evidence of the Importance ofRIT1in Noonan Syndrome","volume":"164","author":"Bertola","year":"2014","journal-title":"Am. J. Med. Genet."},{"key":"B8","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.hfc.2017.12.005","article-title":"Clinical Presentation and Natural History of Hypertrophic Cardiomyopathy in RASopathies","volume":"14","author":"Calcagni","year":"2018","journal-title":"Heart Fail. Clin."},{"key":"B9","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1002\/bdr2.1670","article-title":"Atypical Cardiac Defects in Patients with RASopathies: Updated Data on CARNET Study","volume":"112","author":"Calcagni","year":"2020","journal-title":"Birth Defects Res."},{"key":"B10","doi-asserted-by":"publisher","first-page":"11473","DOI":"10.1073\/pnas.1324128111","article-title":"Next-generation Sequencing Identifies Rare Variants Associated with Noonan Syndrome","volume":"111","author":"Chen","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2020-0167","article-title":"Severe Lymphatic Disorder Resolved with MEK Inhibition in a Patient with Noonan Syndrome and SOS1 Mutation","volume":"146","author":"Dori","year":"2020","journal-title":"Pediatrics"},{"key":"B12","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/365781a0","article-title":"The Pathway to Signal Achievement","volume":"365","author":"Egan","year":"1993","journal-title":"Nature"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1038\/ng.2734","article-title":"The Integrated Landscape of Driver Genomic Alterations in Glioblastoma","volume":"45","author":"Frattini","year":"2013","journal-title":"Nat. Genet."},{"key":"B14","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ppedcard.2015.01.002","article-title":"Cardiomyopathies in Noonan Syndrome and the Other RASopathies","volume":"39","author":"Gelb","year":"2015","journal-title":"Prog. Pediatr. Cardiol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"2310","DOI":"10.1002\/ajmg.a.36646","article-title":"Contribution ofRIT1mutations to the Pathogenesis of Noonan Syndrome: Four New Cases and Further Evidence of Heterogeneity","volume":"164","author":"Gos","year":"2014","journal-title":"Am. J. Med. Genet."},{"key":"B16","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1017\/s1047951117002827","article-title":"Results of Balloon Pulmonary Valvoplasty in Children with Noonan's Syndrome","volume":"28","author":"Holzmann","year":"2018","journal-title":"Cardiol. Young"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1038\/gim.2017.249","article-title":"Autosomal Recessive Noonan Syndrome Associated with Biallelic LZTR1 Variants","volume":"20","author":"Johnston","year":"2018","journal-title":"Genet. Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1002\/ajmg.a.62716","article-title":"The Seventh International RASopathies Symposium: Pathways to a Cure-Expanding Knowledge, Enhancing Research, and Therapeutic Discovery","volume":"188","author":"Kontaridis","year":"2022","journal-title":"Am. J. Med. Genet. A"},{"key":"B19","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1093\/hmg\/4.4.541","article-title":"Isolation and Characterization of a Novel Gene Deleted in DiGeorge Syndrome","volume":"4","author":"Kurahashi","year":"1995","journal-title":"Hum. Mol. Genet."},{"key":"B20","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1002\/ajmg.a.62529","article-title":"Genotype\u2010cardiac Phenotype Correlations in a Large Single\u2010center Cohort of Patients Affected by RASopathies: Clinical Implications and Literature Review","volume":"188","author":"Leoni","year":"2022","journal-title":"Am. J Med Genet. Pt A"},{"key":"B21","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1002\/humu.21492","article-title":"SOS1 Mutations in Noonan Syndrome: Molecular Spectrum, Structural Insights on Pathogenic Effects, and Genotype-Phenotype Correlations","volume":"32","author":"Lepri","year":"2011","journal-title":"Hum. Mutat."},{"key":"B22","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/ajmg.c.31765","article-title":"Congenital Heart Defects in Noonan Syndrome: Diagnosis, Management, and Treatment","volume":"184","author":"Linglart","year":"2020","journal-title":"Am. J. Med. Genet."},{"key":"B23","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.hfc.2021.07.004","article-title":"Hypertrophic Cardiomyopathy in RASopathies","volume":"18","author":"Lioncino","year":"2022","journal-title":"Heart Fail. Clin."},{"key":"B24","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1002\/humu.10129","article-title":"PTPN11 Mutations in Noonan Syndrome Type I: Detection of Recurrent Mutations in Exons 3 and 13","volume":"20","author":"Maheshwari","year":"2002","journal-title":"Hum. Mutat."},{"key":"B25","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/s0022-3476(99)70088-0","article-title":"Congenital Heart Diseases in Children with Noonan Syndrome: An Expanded Cardiac Spectrum with High Prevalence of Atrioventricular Canal","volume":"135","author":"Marino","year":"1999","journal-title":"J. Pediatr."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1161\/01.cir.89.4.1751","article-title":"Independent Predictors of Long-Term Results after Balloon Pulmonary Valvuloplasty. Valvuloplasty and Angioplasty of Congenital Anomalies (VACA) Registry Investigators","volume":"89","author":"McCrindle","year":"1994","journal-title":"Circulation"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e003327","DOI":"10.1161\/CIRCGEN.121.003327","article-title":"Molecular Management of Multifocal Atrial Tachycardia in Noonan's Syndrome with MEK1\/2 Inhibitor Trametinib","volume":"14","author":"Meisner","year":"2021","journal-title":"Circ. Genom Precis. Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1002\/ajmg.a.40456","article-title":"Mek Inhibitor Reverses Hypertrophic Cardiomyopathy in RIT1 Mutated Noonan Syndrome: For the First Time, Hypertrophic Cardiomyopathy Was Reversed in Noonan Syndrome Associated with a RIT1 Mutation","volume":"179","year":"2019","journal-title":"Am. J. Med. Genet. A"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3390\/genes13010006","article-title":"MEK Inhibition in a Newborn with RAF1-Associated Noonan Syndrome Ameliorates Hypertrophic Cardiomyopathy but Is Insufficient to Revert Pulmonary Vascular Disease","volume":"13","author":"Mussa","year":"2021","journal-title":"Genes. (Basel)"},{"key":"B30","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1136\/jmg.2008.057653","article-title":"Noonan and Cardio-Facio-Cutaneous Syndromes: Two Clinically and Genetically Overlapping Disorders","volume":"45","author":"Nystr\u00f6m","year":"2008","journal-title":"J. Med. Genet."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1038\/ng2073","article-title":"Gain-of-function RAF1 Mutations Cause Noonan and LEOPARD Syndromes with Hypertrophic Cardiomyopathy","volume":"39","author":"Pandit","year":"2007","journal-title":"Nat. Genet."},{"key":"B32","first-page":"1","article-title":"Noonan Syndrome: A Review","volume":"33","author":"Patton","year":"1994"},{"key":"B33","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/ng.2855","article-title":"Germline Loss-Of-Function Mutations in LZTR1 Predispose to an Inherited Disorder of Multiple Schwannomas","volume":"46","author":"Piotrowski","year":"2014","journal-title":"Nat. Genet."},{"key":"B34","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/archdischild-2013-305047","article-title":"Cardiovascular Disease in Noonan Syndrome","volume":"99","author":"Prendiville","year":"2014","journal-title":"Archives Dis. Child."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1038\/ng2078","article-title":"Germline Gain-Of-Function Mutations in RAF1 Cause Noonan Syndrome","volume":"39","author":"Razzaque","year":"2007","journal-title":"Nat. Genet."},{"key":"B36","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and Guidelines for the Interpretation of Sequence Variants: a Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1542\/peds.2009-3207","article-title":"Noonan Syndrome: Clinical Features, Diagnosis, and Management Guidelines","volume":"126","author":"Romano","year":"2010","journal-title":"Pediatrics"},{"key":"B38","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1093\/oxfordjournals.eurheartj.a061452","article-title":"The Noonan Syndrome","volume":"4","author":"Sanchez-Cascos","year":"1983","journal-title":"Eur. Heart J."},{"key":"B39","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1002\/humu.20955","article-title":"GermlineBRAFmutations in Noonan, LEOPARD, and Cardiofaciocutaneous Syndromes: Molecular Diversity and Associated Phenotypic Spectrum","volume":"30","author":"Sarkozy","year":"2009","journal-title":"Hum. Mutat."},{"key":"B40","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1136\/adc.2006.104547","article-title":"The Natural History of Noonan Syndrome: a Long-Term Follow-Up Study","volume":"92","author":"Shaw","year":"2007","journal-title":"Arch. Dis. Child."},{"key":"B41","doi-asserted-by":"publisher","first-page":"e1325","DOI":"10.1542\/peds.2006-0211","article-title":"The Spectrum of Cardiac Anomalies in Noonan Syndrome as a Result of Mutations in the PTPN11 Gene","volume":"119","author":"Sznajer","year":"2007","journal-title":"Pediatrics"},{"key":"B42","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1152\/physrev.2001.81.1.153","article-title":"Small GTP-Binding Proteins","volume":"81","author":"Takai","year":"2001","journal-title":"Physiol. Rev."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1086\/340847","article-title":"PTPN11 Mutations in Noonan Syndrome: Molecular Spectrum, Genotype-Phenotype Correlation, and Phenotypic Heterogeneity","volume":"70","author":"Tartaglia","year":"2002","journal-title":"Am. J. Hum. Genet."},{"key":"B44","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/ng772","article-title":"Mutations in PTPN11, Encoding the Protein Tyrosine Phosphatase SHP-2, Cause Noonan Syndrome","volume":"29","author":"Tartaglia","year":"2001","journal-title":"Nat. Genet."},{"key":"B45","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1159\/000276766","article-title":"Noonan Syndrome: Clinical Aspects and Molecular Pathogenesis","volume":"1","author":"Tartaglia","year":"2010","journal-title":"Mol. Syndromol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.gde.2009.04.001","article-title":"The RASopathies: Developmental Syndromes of Ras\/MAPK Pathway Dysregulation","volume":"19","author":"Tidyman","year":"2009","journal-title":"Curr. Opin. Genet. Dev."},{"key":"B47","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.ahj.2012.04.018","article-title":"Outcomes in Children with Noonan Syndrome and Hypertrophic Cardiomyopathy: a Study from the Pediatric Cardiomyopathy Registry","volume":"164","author":"Wilkinson","year":"2012","journal-title":"Am. Heart J."},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1007\/s10557-022-07324-0","article-title":"An Assessment of the Therapeutic Landscape for the Treatment of Heart Disease in the RASopathies","author":"Yi","year":"2022","journal-title":"Cardiovasc Drugs Ther."},{"key":"B49","doi-asserted-by":"publisher","first-page":"3359","DOI":"10.1210\/jc.2003-032091","article-title":"Protein-tyrosine Phosphatase, Nonreceptor Type 11 Mutation Analysis and Clinical Assessment in 45 Patients with Noonan Syndrome","volume":"89","author":"Yoshida","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2022.915129\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T05:17:56Z","timestamp":1655097476000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2022.915129\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,13]]},"references-count":49,"alternative-id":["10.3389\/fgene.2022.915129"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2022.915129","relation":{},"ISSN":["1664-8021"],"issn-type":[{"value":"1664-8021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,13]]},"article-number":"915129"}}